Itron (NASDAQ:ITRI) SVP Sells $15,044.40 in Stock

Itron, Inc. (NASDAQ:ITRIGet Free Report) SVP Christopher Ware sold 189 shares of the stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $79.60, for a total transaction of $15,044.40. Following the completion of the sale, the senior vice president directly owned 30,506 shares of the company’s stock, valued at $2,428,277.60. The trade was a 0.62% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Trading Up 1.1%

Shares of Itron stock traded up $0.93 during trading hours on Thursday, hitting $82.28. The company’s stock had a trading volume of 376,875 shares, compared to its average volume of 937,478. Itron, Inc. has a 1-year low of $77.77 and a 1-year high of $142.00. The business has a fifty day moving average of $88.85 and a 200 day moving average of $94.73. The company has a market capitalization of $3.65 billion, a PE ratio of 13.15, a P/E/G ratio of 0.68 and a beta of 1.35. The company has a quick ratio of 2.24, a current ratio of 2.66 and a debt-to-equity ratio of 0.97.

Itron (NASDAQ:ITRIGet Free Report) last released its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.23. Itron had a net margin of 12.31% and a return on equity of 19.54%. The company had revenue of $586.98 million during the quarter, compared to analyst estimates of $572.04 million. During the same quarter in the prior year, the business earned $1.52 earnings per share. The business’s quarterly revenue was down 3.3% compared to the same quarter last year. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. As a group, equities analysts forecast that Itron, Inc. will post 6.01 EPS for the current year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in ITRI. Impax Asset Management Group plc boosted its stake in Itron by 127.3% during the 3rd quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock valued at $197,153,000 after acquiring an additional 890,040 shares during the last quarter. Norges Bank bought a new position in Itron during the 4th quarter valued at $63,990,000. Soros Fund Management LLC bought a new position in Itron during the 4th quarter valued at $34,843,000. Millennium Management LLC boosted its stake in Itron by 269.3% during the 4th quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock valued at $47,068,000 after acquiring an additional 369,617 shares during the last quarter. Finally, Merewether Investment Management LP boosted its stake in Itron by 1,552.7% during the 2nd quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock valued at $39,593,000 after acquiring an additional 282,587 shares during the last quarter. 96.19% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. JPMorgan Chase & Co. lowered their price target on shares of Itron from $133.00 to $113.00 and set an “overweight” rating for the company in a report on Thursday, April 16th. Raymond James Financial assumed coverage on shares of Itron in a report on Tuesday, April 21st. They set an “underperform” rating for the company. Needham & Company LLC assumed coverage on shares of Itron in a report on Friday, March 6th. They set a “buy” rating and a $124.00 price target for the company. Zacks Research raised shares of Itron from a “strong sell” rating to a “hold” rating in a report on Thursday, February 26th. Finally, Guggenheim set a $155.00 price target on shares of Itron in a report on Friday, February 13th. Eight analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Itron has a consensus rating of “Moderate Buy” and a consensus target price of $131.22.

Get Our Latest Analysis on Itron

About Itron

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Featured Stories

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.